Erythromycin A-Derived Macrolides Modify the Functional Activities of Human Neutrophils by Altering the Phospholipase D-Phosphatidate Phosphohydrolase Transduction Pathway: L-Cladinose Is Involved Both in Alterations of Neutrophil Functions and Modulation of This Transductional Pathway

Journal of Immunology

Volumn 159, Issue 8, 1997, Pages 3995-4005

  Abdelghaffar, Houria ^a   Vazifeh, Doina ^a   Labro, Marie Thérèse ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CLADINOSE; DIACYLGLYCEROL; DRUG DERIVATIVE; ERYTHROMYCIN; GLYCEROPHOSPHOLIPID; HEXOSE; PHOSPHATIDATE PHOSPHATASE; PHOSPHATIDIC ACID; PHOSPHATIDYLETHANOL; PHOSPHOLIPASE D; ROXITHROMYCIN; SUPEROXIDE;

ARTICLE; BIOSYNTHESIS; BLOOD; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; EXOCYTOSIS; HUMAN; IMMUNOLOGY; INTERPHASE; KINETICS; LEUKOCYTE ACTIVATION; NEUTROPHIL; PHYSIOLOGY; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

DIGLYCERIDES; ENZYME ACTIVATION; ERYTHROMYCIN; EXOCYTOSIS; GLYCEROPHOSPHOLIPIDS; HEXOSES; HUMANS; INTERPHASE; KINETICS; NEUTROPHIL ACTIVATION; NEUTROPHILS; PHOSPHATIDATE PHOSPHATASE; PHOSPHATIDIC ACIDS; PHOSPHOLIPASE D; ROXITHROMYCIN; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; SUPEROXIDES;

EID: 0031572435     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Kirst, H. A., and G. D. Sides. 1989. New directions for macrolide antibiotics: pharmacokinetics and clinical efficacy. Antimicrob. Agents Chemother. 33:1419.
2. Fernandes, P. B 1987. The macrolide revival: thirty-five years after erythromycin. Antimicrob. Newsl. 4:25.
3. Labro, M. T. 1993. Intraphagocytic penetration of macrolides. In Macrolides: Chemistry, Pharmacology and Clinical Use. J. P. Butzler, A. Bryskier, H. C. Neu, and P. M. Tulkens, eds. Arnette-Blackwell, Paris, p. 379.
4. Labro, M. T. 1993. Effects of macrolides on host natural defences. In Macrolides: Chemistry, Pharmacology and Clinical Use. J. P. Butzler, A. Bryskier, H. C. Neu, and P. M. Tulkens, eds. Arnette-Blackwell, Paris, p. 389.
5. Labro, M. T., J. El Benna, and C. Babin-Chevaye. 1989. Comparison of the in-vitro effect of several macrolides on the oxidative burst of human neutrophils. J. Antimicrob. Chemother. 24:561.
6. Anderson, R. 1989. Erythromycin and roxithromycin potentiate human neutrophil locomotion in vitro by inhibition of leukoattractant-activated superoxide generation and autooxidation. J. Infect. Dis. 159:966.
7. Hand, W. L., H. L. Hand, and N. L. King-Thompson. 1990. Antibiotic inhibition of the respiratory burst response in human polymorphonuclear leukocytes. Antimicrob. Agents Chemother. 34:863.
8. Jooné, G. K., C. E. J. Van Rensburg, and R. Anderson. 1992. Investigation of the in-vitro uptake, intraphagocytic biological activity and effects of neutrophil superoxide generation of dirithromycin compared with erythromycin. J. Antimicrob. Chemother. 30:509.
9. Hand, W. L., and D. L. Hand. 1993. Interactions of dirithromycin with human polymorphonuclear leukocytes. Antimicrob. Agents Chemother. 37:2557.
10. Labro, M. T., J. El Benna, and H. Abdelghaffar. 1993. Modulation of human polymorphonuclear neutrophil function by macrolides: preliminary data concerning dirithromycin. J. Antimicrob. Chemother. 31(Suppl. C):51.
11. Abdelghaffar, H., E. M. Mtairag, and M. T. Labro. 1994. Effects of dirithromycin and erythromycylamine on human neutrophil degranulation. Antimicrob. Agents Chemother. 38:1548.
12. Abdelghaffar, H., D. Vazifeh, and M. T. Labro. 1996. Comparison of various macrolides for stimulation of human neutrophil degranulation in vitro. J. Antimicrob. Chemother. 38:81.
13. Villa, M. L., F. Valenti, F. Scaglione, M. Falchi, and F. Fraschini. 1989. In-vivo and in-vitro interference of antibiotics with antigen-specific antibody responses: effect of josamycin. J. Antimicrob. Chemother. 24:765.
14. English, D. 1992. Involvement of phosphatidic acid, phosphatidate phosphohydrolase and inositide-specific phospholipase D in neutrophil stimulus-response pathways. J. Lab. Clin. Med. 120:520.
15. Perry, D. K., W. L. Hand, D. E. Edmondson, and J. D. Lambeth. 1992. Role of phospholipase D-derived diradyl-glycerol in the activation of the human neutrophil respiratory burst oxidase. J. Immunol. 149:2749.
16. Billah, M. M. 1993. Phospholipase D and cell signaling. Curr. Opin. Immunol. 5:114.
17. Morris, A. J., J. Engebrecht, and M. A. Frohman. 1996. Structure and regulation of phospholipase D. Trends Pharmacol. Sci. 17:182.
18. Stutchfield, J., and S. Cockroft. 1993. Correlation between secretion and phospholipase D activation in differentiated HL 60 cells. Biochem. J. 293:649.
19. McPhail, L., D. Qualliottine-Mann, and K. A. White. 1995. Cell-free activation of neutrophil NADPH oxidase by a phosphatidic acid-regulated protein kinase. Proc. Natl. Acad. Sci. USA 92:7931.
20. Bergmeyer, H. U. 1963. Methods in Enzymatic Analysis. Academic Press, New York.
21. Cohen, H. J., and M. E. Chovaniec. 1978. Superoxide generation by digitonin-stimulated guinea pig granulocytes. J. Clin. Invest. 61:1081.
22. Watson, F., G. M. Lowe, J. J. Robinson, D. W. Galvani, and S. W. Edwards. 1994. Phospholipase D-dependent and independent activation of the neutrophil NADPH oxidase. Biosci. Rep. 14:91.
23. Djerdjouri, B., E. Pedruzzi, J. Hakim, and A. Périanin. 1994. Okadaic acid, an inhibitor of type 1 and type 2A phosphatases, modulates the activation of phospholipase in formyl peptide- and mastoparan-stimulated human neutrophils. Biochem. Biophys. Res. Commun. 205:1481.
24. 4 and formyl-methionyl-leucyl-phenylalanine in rabbit neutrophils. J. Immunol. 146:3536.
25. Labro, M. T. 1996. Intracellular bioactivity of macrolides. Clin. Microb. Infect. 1(Suppl. 1):S24.
26. Gustavsson, L. 1995. Phosphatidylethanol formation: specific effects of ethanol mediated via phospholipase D. Alcohol Alcohol. 30:391.
27. Labro, M. T., H. Abdelghaffar, C. Douhet, and A. Bryskier. 1995. Investigation of the mechanism underlying the stimulation of neutrophil (PMN) exocytosis by macrolides. In Program and Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington DC, p. 165 (Abstr. G39).
28. Billah, M. M., and J. C. Anthes. 1990. The regulation and cellular functions of phosphatidyl choline hydrolysis. Biochem. J. 269:281.
29. Babior, B. M. 1978. Oxygen-dependent microbial killing by phagocytes. N. Engl. J. Med. 298:659.
30. Roos, D. 1991. The involvement of oxygen radicals in microbicidal mechanisms of leukocytes and macrophages. Klin. Wochenschr. 69:975.
31. Haslett, C., J. S. Savill, and L. Meagher. 1989. The neutrophil. Curr. Opin. Immunol. 2:10.
32. Leff, J. A., and J. E. Repine. 1993. Neutrophil-mediated tissue injury. In The Neutrophil. J. S. Abramson and J. A. Wheeler, eds. IRL Press, New York, p. 229.
33. Shapira, L., B. Gordon, M. Warrington, and T. E. Van Dyke. 1994. Priming effect of Porphyromonas gingivalis lipopolysaccharide on superoxide production by neutrophils from healthy and rapidly progressive periodontitis subjects. J. Periodontol. 65:129.
34. Miesel, R., D. Sanocka, M. Kurpisz, and H. Kröger. 1995. Antiinflammatory effects of NADPH oxidase inhibitors. Inflammation 19:347.
35. Oyanagi, T. 1978. Inhibition of superoxide anion production in non-stimulated guinea pig peritoneal exudate cells by anti-inflammatory drugs. Biochem. Pharmacol. 27:777.
36. Cross, A. R. 1990. Inhibitors of the leukocyte superoxide generating oxidase. Free Radical Biol. Med. 8:71.
37. Labro, M. T. 1993. Immunomodulation by antibacterial agents: is it clinically relevant? Drugs 45:319.
38. Labro, M. T. 1996. Immunomodulatory action of antibacterial agents. Clin. Immunother. 6:454.
39. Agen, C., R. Danesi, C. Blandizzi, M. Costa, B. Stacchini, P. Favini, and M. Del Tacca. 1993. Macrolide antibiotics as antiinflammatory agents: roxithromycin in an unexpected role. Agents Actions 38:85.
40. Mikasa, K., E. Kita, M. Sawaki, M. Kunimatsu, K. Hamada, M. Konishi, S. Kashiba, and N. Narita. 1992. The antiinflammatory effect of erythromycin in zymosan-induced peritonitis of mice. J. Antimicrob. Chemother. 30:339.
41. Tamaoki, J., N. Sakai, E. Tagaya, and K. Kono. 1994. Macrolide antibiotics protect against endotoxin-induced vascular leakage and neutrophil accumulation in rat trachea. Antimicrob. Agents Chemother. 38:1641.
42. Tarayre, J. P., M. Aliaga, M. Barbara, G. Villanova. R. Ballester, J. Tisne-Versailles, and J. P. Couzinier. 1987. Cutaneously applied erythromycin base reduces various types of inflammatory reactions in mouse ear. Int. J. Tissue React. 9:77.
43. Nagai, H., H. Shishido, R. Yoneda, E. Yamaguchi, A. Tamura, and A. Kurashima. 1991. Long-term low-dose administration of erythromycin to patients with diffuse panbronchiolitis. Respiration 58:145.
44. Miyatake, H., F. Taki, H. Taniguchi, R. Suzuki, T. Takagi, and T. Satake. 1991. Erythromycin reduces the severity of bronchial hyperresponsiveness in asthma. Chest 99:670.
45. Agouridas, C., A. Bonnefoy, K. Braham, P. Collett, M. Guitton, P. Mauvais, and J. F. Chanto. 1995. RU 004 uptake by phagocytes, intracellular bioactivity and other immunomodulatory effects. Program and Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, DC, p. 143 (Abstr. F-175).
46. Labro, M. T., H. Abdelghaffar, and A. Bryskier. 1996. Characteristics of the cellular accumulation of RU004 by human neutrophils (PMN): comparison with azithromycin and roxithromycin. Program and Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, DC, p. 139 (Abstr. F-224).
47. Tauber, A. I. 1987. Protein kinase C and the activation of the human neutrophil NADPH-oxidase. Blood 69:711.
48. Wenezl-Seifert, K., C. Schächtele, and R. Seifert. 1994. N-protein kinase C isoenzymes may be involved in the regulation of various neutrophil functions. Biochem. Biophys. Res. Commun. 200:1536.
49. Babior, B. M. 1994. Activation of the respiratory burst oxidase. Environ. Health Perspect. 102(Suppl. 10):53.
50. Dusi, S., and F. Rossi. 1993. Activation of NADPH oxidase of human neutrophils involves the phosphorylation and the translocation of cytosolic p67 phox. Biochem. J. 296:367.
51. Kessels, G. C. R., D. Roos, and A. J. Verhoeven. 1991. fMet-Leu-Phe-induced activation of phospholipase D in human neutrophils. J. Biol. Chem. 266:23151.
52. Reinhold, S. L., S. M. Prescott, G. A. Zimmerman, and T. M. Mc Intyre. 1990. Activation of human neutrophil phospholipase D by three separable mechanisms. FASEB J. 4:208.
53. Kessels, G. C. R., K. H. Krause, and A. J. Verhoeven. 1993. Protein kinase C activity is not involved in N-formylmethionyl-leucyl-phenylalanine-induced phospholipase D activation in human neutrophils, but is essential for concomitant NADPH oxidase activation: studies with a staurosporine analogue with improved selectivity for protein kinase C. Biochem. J. 292:781.
54. Bergogne-Berezin, E. 1993. Tissue distribution of macrolide antibiotics. In Macrolides: Chemistry, Pharmacology and Clinical Use. J. P. Butzler, A. Bryskier, H. C. Neu, and P. M. Tulkens, eds. Arnette-Blackwell, Paris, p. 451.